A study published in Lancet Oncology on June 9th, 2015 finds that one dose of the HPV vaccine might be effective for HPV infection prevention. Researchers from the U.S. National Cancer Institute and other organizations reviewed trials that were previously conducted on 24,000 young women. The goal was to estimate how much protection the women were able to receive from different numbers of doses. Vaccine efficacy against incident HPV-16/18 infections for three doses was 77.0% (95% CI 74.7–79.1), two doses ...
A key role of obstetrician/gynecologists and other healthcare providers is to provide patients and their parents with information on the benefits and safety of the HPV vaccine, and to encourage adolescents to receive this vaccine. The American College of Obstetricians and Gynecologists (ACOG) updated its 2014 recommendations to include the new 9-valent HPV vaccine, also recommended by CDC for girls and boys aged 11 to 12 years. Those who do not receive the HPV vaccine during the target age range should ...
CCFC is excited to announce our upcoming webinar series, “Strategies to increase HPV vaccination among your patients”. The first webinar, “Provider interventions to increase HPV vaccination in the United States: A successful quality improvement example”, will be led by Alix Casler, MD, FAAP.
Date: Thursday September 3, 2015
Time: 5:30 – 6:30 PM EDT
Webinar link: https://uncsph.adobeconnect.com/sgee
Phone number: 919-962-2733 (This telephone number will provide sound for the webinar.)
Dr. Casler will refer to the following documents during her presentation, which are shared with permission from ...
On April 23, 2015, the American Journal of Public Health published a new study conducted in Los Angles, California from 2011-2012. Researchers surveyed Non-Hispanic White, Mexican American, and African American women age25 to 45 on their cervical cancer-related knowledge, attitudes, and behavior. Participants were randomly assigned to watch either a narrative or a nonnarative film which contained the same information on cervical cancer prevention. At 6 months post-intervention, women who watched the narrative film were considerably more likely to have ...
“Must-See: HPV Epidemic Documentary “Someone You Love” Hits Home And Hits Hard”
http://www.forbes.com/sites/tarahaelle/2015/07/21/must-see-hpv-epidemic-documentary-someone-you-love-hits-home-and-hits-hard/
A key role of obstetrician/gynecologists and other healthcare providers is to provide patients and their parents with information on the benefits and safety of the human papillomavirus (HPV) vaccine and to encourage adolescents to receive the HPV immunization, according to updated recommendations published online by the American College of Obstetricians and Gynecologists. ACOG updated its March 2014 recommendations to include the new 9-valent HPV vaccine, also recommended by the Centers for Disease Control and Prevention (CDC) for girls and boys ...
On Friday, June 26, 2015 at 12:00PM ET there will be another #PreteenVaxScene webinar! Register now for this at https://attendee.gotowebinar.com/register/6017466976921946370.
This webinar will have various speakers such as:
Cindy Weinbaum MD MPH, Acting Executive Secretary of the ACIP, will summarize adolescent-related highlights from the June 24-25th ACIP meeting related to meningococcal B vaccine; 9-valent HPV vaccination; and the General Recommendations on Immunization.
Ian Branam (Health Communication Specialist, TEKsystems Inc.) from NCIRD’s health communication science office (HCSO) will discuss plans and activities for National Immunization Awareness Month and ...
On June 16th 2015, new research published in the British Medical Journal found that more than half of cervical cancer deaths occur in women over age 65. Chief researcher Dr. Sue Sherman proposed this high mortality rate is due to older women not going in for regular screenings. The perception that cervical cancer impacts only young women is one of the leading contributors to the lack of screening. Dr. Sue Sherman states, “As the population ages, this number of older women affected is set ...
Researchers from the U.S. National Cancer Institute and other organizations looked through trials that were previously conducted on 24,000 young women. The goal was to estimate how much of a protection the women were able to receive from various levels of doses. Vaccine efficacy against incident HPV-16/18 infections for three doses was 77·0% (95% CI 74·7–79·1), two doses was 76·0% (62·0–85·3), and one dose was 85·7% (70·7–93·7).A change in dosage could increase the number of young women vaccinated by reducing ...